Palomino Laboratories (PALX) Shares Outstanding (Weighted Average) (2022 - 2025)

Palomino Laboratories' Shares Outstanding (Weighted Average) history runs 4 years deep, the most recent figure standing at $6.7 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 340.48% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $6.7 million (up 340.48% YoY), while the FY2025 annual figure was $6.7 million, up 340.48% from the prior year.
• Shares Outstanding (Weighted Average) came in at $6.7 million for Q4 2025 at Palomino Laboratories, down from $7.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $7.5 million in Q3 2025 to a low of $1.5 million in Q4 2024.
• A 4-year average of $4.6 million and a median of $5.0 million in 2022 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 69.53% in 2024 and soared 350.86% in 2025, its largest moves.
• Palomino Laboratories' Shares Outstanding (Weighted Average) stood at $5.0 million in 2022, then changed by 0.0% to $5.0 million in 2023, then slumped by 69.53% to $1.5 million in 2024, then jumped by 340.48% to $6.7 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $6.7 million, $7.5 million, and $5.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison